- Home
- BLDE vs VSTM Comparison
BLDE vs VSTM Comparison
Compare BLDE & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDE
- VSTM
- Stock Information
- Founded
- BLDE 2014
- VSTM 2010
- Country
- BLDE United States
- VSTM United States
- Employees
- BLDE N/A
- VSTM N/A
- Industry
- BLDE Aerospace
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- BLDE Consumer Discretionary
- VSTM Health Care
- Exchange
- BLDE Nasdaq
- VSTM Nasdaq
- Market Cap
- BLDE 272.5M
- VSTM 313.1M
- IPO Year
- BLDE N/A
- VSTM 2012
- Fundamental
- Price
- BLDE $2.55
- VSTM $6.21
- Analyst Decision
- BLDE Strong Buy
- VSTM Strong Buy
- Analyst Count
- BLDE 2
- VSTM 9
- Target Price
- BLDE $6.25
- VSTM $13.13
- AVG Volume (30 Days)
- BLDE 642.1K
- VSTM 893.4K
- Earning Date
- BLDE 05-06-2025
- VSTM 05-08-2025
- Dividend Yield
- BLDE N/A
- VSTM N/A
- EPS Growth
- BLDE N/A
- VSTM N/A
- EPS
- BLDE N/A
- VSTM N/A
- Revenue
- BLDE $248,693,000.00
- VSTM $10,000,000.00
- Revenue This Year
- BLDE $5.21
- VSTM $7.68
- Revenue Next Year
- BLDE $8.70
- VSTM $605.06
- P/E Ratio
- BLDE N/A
- VSTM N/A
- Revenue Growth
- BLDE 10.44
- VSTM N/A
- 52 Week Low
- BLDE $2.35
- VSTM $2.10
- 52 Week High
- BLDE $5.17
- VSTM $13.52
- Technical
- Relative Strength Index (RSI)
- BLDE 37.66
- VSTM 56.83
- Support Level
- BLDE $2.59
- VSTM $4.69
- Resistance Level
- BLDE $2.81
- VSTM $5.12
- Average True Range (ATR)
- BLDE 0.21
- VSTM 0.56
- MACD
- BLDE 0.01
- VSTM 0.07
- Stochastic Oscillator
- BLDE 37.38
- VSTM 93.97
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.